Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease.
about
Spreading of pathology in neurodegenerative diseases: a focus on human studiesWeight Change Is a Characteristic Non-Motor Symptom in Drug-Naïve Parkinson's Disease Patients with Non-Tremor Dominant Subtype: A Nation-Wide Observational StudyHippocampal proliferation is increased in presymptomatic Parkinson's disease and due to microglia.Microglial phenotypes and toll-like receptor 2 in the substantia nigra and hippocampus of incidental Lewy body disease cases and Parkinson's disease patients.Expectation modulates the effect of deep brain stimulation on motor and cognitive function in tremor-dominant Parkinson's disease.Patterns of Motor and Non-Motor Features in Medication-Naïve ParkinsonismCSF biomarkers associated with disease heterogeneity in early Parkinson's disease: the Parkinson's Progression Markers Initiative study.Neuropathological Staging of Brain Pathology in Sporadic Parkinson's disease: Separating the Wheat from the Chaff.Dysfunction of the locus coeruleus-norepinephrine system and related circuitry in Parkinson's disease-related dementia.Models of α-synuclein aggregation in Parkinson's disease.Review: Parkinson's disease: from synaptic loss to connectome dysfunction.Failing as doorman and disc jockey at the same time: Amygdalar dysfunction in Parkinson's disease.Review: Sporadic Parkinson's disease: development and distribution of α-synuclein pathology.Potential Pathways of Abnormal Tau and α-Synuclein Dissemination in Sporadic Alzheimer's and Parkinson's Diseases.An order in Lewy body disorders: Retrograde degeneration in hyperbranching axons as a fundamental structural template accounting for focal/multifocal Lewy body disease.Habitual behavior and dopamine cell vulnerability in Parkinson disease.Clinical subtypes in Parkinson's disease: the impact of MAPT haplotypes.Autonomic Function Tests and MIBG in Parkinson's Disease: Correlation to Disease Duration and Motor Symptoms.Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis.Quality Over Quantity: Advantages of Using Alpha-Synuclein Preformed Fibril Triggered Synucleinopathy to Model Idiopathic Parkinson's Disease
P2860
Q28082279-902DF5D1-E2EB-4A05-9EC8-86D51D65508EQ28554041-D9D1407E-6B17-41AD-8DDA-E5E4CDE6E9B6Q34100703-CC56FEB9-7B7D-4E29-916B-80858AD7E7D7Q34470963-6C8E79D0-F18A-4D12-ADAB-FC966AC62832Q35061374-1C967780-745F-498B-9FE6-E95F3630D3A6Q35977440-FFAA5735-8E4D-4C10-A916-A19E88423AC9Q37272860-51785C00-A5B5-4415-9DC6-DFA0F751C669Q37693339-C285A319-C9AB-46E1-A4F5-D61E3A8F8EADQ38051969-C29F97BC-73B2-41FB-97B4-A982EA4FF4E1Q38286574-B2DE960D-DA89-499E-B037-7F9D3A5C80BDQ38650395-2899D84E-D10F-48FD-AE8A-6098E040FF4EQ38663822-1718B07C-CA29-4594-902B-B4E3D95FDE99Q38667942-88BF3694-B7CD-47F1-BF93-01355AD15FC2Q38942540-EE46B59D-EAC1-47A3-A4E4-CFA341C84C8EQ39012982-F5B3AC26-9DCE-4DB4-9B4C-7F93B2261F6BQ42177449-5DF62190-49B4-493E-8A23-09E3526F78FEQ45009668-B55A271C-84D3-4CAC-AC95-687E75F7D3FFQ51610318-56349697-E0C7-4B40-9F9E-D1F92F1A3B1FQ53512696-BEC6D995-2EF3-40CE-8EA4-041EBB0C6803Q58764665-8A4FCD10-ED4F-4489-BFA4-89774B165C2C
P2860
Patterns of α-synuclein pathology in incidental cases and clinical subtypes of Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Patterns of α-synuclein pathol ...... btypes of Parkinson's disease.
@en
Patterns of α-synuclein pathol ...... btypes of Parkinson's disease.
@nl
type
label
Patterns of α-synuclein pathol ...... btypes of Parkinson's disease.
@en
Patterns of α-synuclein pathol ...... btypes of Parkinson's disease.
@nl
prefLabel
Patterns of α-synuclein pathol ...... btypes of Parkinson's disease.
@en
Patterns of α-synuclein pathol ...... btypes of Parkinson's disease.
@nl
P2093
P921
P1476
Patterns of α-synuclein pathol ...... btypes of Parkinson's disease.
@en
P2093
Anke A Dijkstra
Dagmar H Hepp
J Annemieke M Rozemuller
Wilma D J van de Berg
P304
P356
10.1016/S1353-8020(11)70011-6
P478
18 Suppl 1
P577
2012-01-01T00:00:00Z